Gan02 0004 01
Ganciclovir Injection, Solution
Product Images NDC 25021-185
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 25021-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gan02 0004 02
Gan02 0004 03
The text seems to show a graph or chart that is related to the progression of CMV retinitis. The x-axis seems to show the time interval in days from the start of maintenance therapy, while the y-axis suggests some kind of progression measure. Unfortunately, the text is not entirely legible, making it difficult to provide a more detailed description.*
Gan02 0004 04
This text is displaying information related to the progression of CMV Retinitis over time since the start of maintenance therapy. The text appears to be a chart or graph with a time axis ranging from 0 to 120 days. No further information regarding the data or context is available.*
Gan02 0004 05
This appears to be a chart or graph related to a study on CMV (cytomegalovirus) Retinitis progression. The chart shows percentages and time frames, possibly indicating the likelihood or rate of progression over time. However, without more context or information, it is difficult to provide a complete and accurate description.*
Gan02 0004 06
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
